Hanall Biopharma Revenue

Hanall Biopharma had revenue of 40.68B KRW in the quarter ending June 30, 2025, with 28.77% growth. This brings the company's revenue in the last twelve months to 150.09B, up 15.12% year-over-year. In the year 2024, Hanall Biopharma had annual revenue of 138.94B with 2.99% growth.

Revenue (ttm)

150.09B

Revenue Growth

+15.12%

P/S Ratio

13.98

Revenue / Employee

493.71M

Employees

304

Market Cap

2.10T

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	138.94B	4.03B	2.99%
Dec 31, 2023	134.91B	24.91B	22.65%
Dec 31, 2022	110.00B	8.40B	8.27%
Dec 31, 2021	101.59B	12.99B	14.66%
Dec 31, 2020	88.60B	-19.85B	-18.30%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	5.03T
Celltrion	3.75T
Yuhan	2.17T
Hanmi Pharm.	1.50T
SK Biopharmaceuticals	620.28B
Sam Chun Dang Pharm.	215.10B
ALTEOGEN	158.06B
LigaChem Biosciences	148.28B

Revenue Rankings